Lisa Hines
Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 51 | 2023 | 1872 | 3.650 |
Why?
| Genetic Predisposition to Disease | 23 | 2017 | 2125 | 1.230 |
Why?
| Receptors, Estrogen | 11 | 2021 | 372 | 1.080 |
Why?
| Polymorphism, Single Nucleotide | 21 | 2022 | 1918 | 0.900 |
Why?
| Case-Control Studies | 35 | 2023 | 3022 | 0.880 |
Why?
| Emigrants and Immigrants | 1 | 2023 | 111 | 0.750 |
Why?
| Alcohol Drinking | 8 | 2017 | 648 | 0.740 |
Why?
| Risk Factors | 38 | 2023 | 8697 | 0.650 |
Why?
| Middle Aged | 53 | 2023 | 26999 | 0.570 |
Why?
| Coronary Disease | 3 | 2005 | 348 | 0.570 |
Why?
| Receptors, Progesterone | 7 | 2021 | 319 | 0.560 |
Why?
| Adenylyl Cyclases | 2 | 2006 | 84 | 0.530 |
Why?
| Adult | 51 | 2023 | 30718 | 0.490 |
Why?
| Substance-Related Disorders | 2 | 2017 | 950 | 0.470 |
Why?
| Suicide, Attempted | 1 | 2017 | 316 | 0.470 |
Why?
| Aged | 42 | 2021 | 19251 | 0.450 |
Why?
| Genetics | 1 | 2014 | 27 | 0.450 |
Why?
| Science | 1 | 2014 | 49 | 0.430 |
Why?
| Menopause | 8 | 2020 | 262 | 0.420 |
Why?
| Female | 62 | 2023 | 59913 | 0.420 |
Why?
| Depressive Disorder, Major | 2 | 2006 | 304 | 0.420 |
Why?
| Suicidal Ideation | 1 | 2017 | 399 | 0.420 |
Why?
| Faculty | 1 | 2014 | 131 | 0.420 |
Why?
| Energy Metabolism | 4 | 2022 | 715 | 0.390 |
Why?
| Mental Health | 1 | 2017 | 571 | 0.390 |
Why?
| Postmenopause | 4 | 2014 | 300 | 0.390 |
Why?
| Phenotype | 4 | 2011 | 2829 | 0.380 |
Why?
| Mammography | 2 | 2009 | 107 | 0.370 |
Why?
| Healthcare Disparities | 9 | 2016 | 485 | 0.370 |
Why?
| Breast Feeding | 3 | 2019 | 370 | 0.360 |
Why?
| Genotype | 13 | 2016 | 1786 | 0.350 |
Why?
| Vocabulary, Controlled | 1 | 2010 | 41 | 0.340 |
Why?
| Alcoholism | 4 | 2017 | 713 | 0.330 |
Why?
| Students | 1 | 2014 | 502 | 0.330 |
Why?
| Sex Characteristics | 4 | 2006 | 641 | 0.320 |
Why?
| Biomarkers, Tumor | 4 | 2022 | 1048 | 0.310 |
Why?
| Humans | 66 | 2023 | 115587 | 0.310 |
Why?
| Diet | 5 | 2015 | 1072 | 0.310 |
Why?
| Alcohol Dehydrogenase | 2 | 2005 | 16 | 0.310 |
Why?
| San Francisco | 4 | 2023 | 56 | 0.310 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2008 | 38 | 0.300 |
Why?
| Polymorphism, Genetic | 3 | 2014 | 621 | 0.290 |
Why?
| Aldehyde Oxidoreductases | 3 | 2004 | 30 | 0.290 |
Why?
| Parity | 4 | 2022 | 99 | 0.290 |
Why?
| Estrogen Replacement Therapy | 1 | 2008 | 116 | 0.290 |
Why?
| Hormones | 2 | 2012 | 132 | 0.270 |
Why?
| United States | 14 | 2023 | 12295 | 0.260 |
Why?
| Mexico | 5 | 2019 | 163 | 0.260 |
Why?
| Odds Ratio | 7 | 2018 | 962 | 0.260 |
Why?
| Lipoproteins, HDL | 1 | 2005 | 76 | 0.240 |
Why?
| Mass Screening | 2 | 2009 | 1024 | 0.240 |
Why?
| Menstruation | 2 | 2021 | 35 | 0.240 |
Why?
| Indians, North American | 6 | 2015 | 584 | 0.240 |
Why?
| Transforming Growth Factor beta | 3 | 2013 | 446 | 0.230 |
Why?
| Life Style | 3 | 2015 | 429 | 0.230 |
Why?
| Algorithms | 2 | 2010 | 1490 | 0.220 |
Why?
| Health Status Disparities | 4 | 2017 | 204 | 0.210 |
Why?
| Aldehyde Dehydrogenase | 2 | 2017 | 129 | 0.210 |
Why?
| Blood Platelets | 1 | 2005 | 350 | 0.210 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2022 | 38 | 0.200 |
Why?
| Southwestern United States | 5 | 2015 | 92 | 0.200 |
Why?
| Genetic Association Studies | 4 | 2022 | 343 | 0.190 |
Why?
| Adiposity | 2 | 2016 | 468 | 0.190 |
Why?
| Logistic Models | 7 | 2020 | 1856 | 0.180 |
Why?
| Age Factors | 6 | 2018 | 2907 | 0.170 |
Why?
| Menarche | 1 | 2020 | 49 | 0.170 |
Why?
| Insulin-Like Growth Factor I | 1 | 2022 | 281 | 0.170 |
Why?
| Genetic Variation | 3 | 2014 | 877 | 0.170 |
Why?
| Smoking | 3 | 2015 | 1457 | 0.170 |
Why?
| Young Adult | 10 | 2021 | 10470 | 0.160 |
Why?
| Premenopause | 4 | 2022 | 103 | 0.160 |
Why?
| Reproductive History | 1 | 2018 | 12 | 0.150 |
Why?
| Body Size | 2 | 2015 | 92 | 0.150 |
Why?
| Body Mass Index | 7 | 2015 | 1971 | 0.140 |
Why?
| Incidence | 6 | 2016 | 2335 | 0.140 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2016 | 76 | 0.130 |
Why?
| Triple Negative Breast Neoplasms | 1 | 2018 | 157 | 0.130 |
Why?
| Cigarette Smoking | 1 | 2017 | 80 | 0.130 |
Why?
| Socioeconomic Factors | 2 | 2017 | 1086 | 0.130 |
Why?
| Matrix Metalloproteinases | 2 | 2013 | 87 | 0.120 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2015 | 277 | 0.120 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2014 | 13 | 0.120 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2014 | 58 | 0.120 |
Why?
| Aromatase | 1 | 2014 | 31 | 0.120 |
Why?
| Oxidative Stress | 2 | 2013 | 1093 | 0.120 |
Why?
| Waist Circumference | 1 | 2014 | 122 | 0.120 |
Why?
| Selenoprotein P | 1 | 2013 | 3 | 0.120 |
Why?
| Immunity | 1 | 2014 | 124 | 0.120 |
Why?
| Postpartum Period | 2 | 2022 | 281 | 0.110 |
Why?
| Women's Health | 3 | 2016 | 271 | 0.110 |
Why?
| Aged, 80 and over | 9 | 2016 | 6417 | 0.110 |
Why?
| Schizosaccharomyces | 1 | 2014 | 54 | 0.110 |
Why?
| Models, Educational | 1 | 2014 | 86 | 0.110 |
Why?
| Endonucleases | 1 | 2013 | 30 | 0.110 |
Why?
| Telomere Homeostasis | 1 | 2013 | 24 | 0.110 |
Why?
| Social Justice | 1 | 2013 | 66 | 0.110 |
Why?
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 39 | 0.110 |
Why?
| Inflammation | 2 | 2014 | 2499 | 0.110 |
Why?
| Genetics, Population | 1 | 2014 | 192 | 0.110 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2012 | 24 | 0.110 |
Why?
| Prognosis | 5 | 2022 | 3339 | 0.110 |
Why?
| Tobacco Smoke Pollution | 1 | 2015 | 221 | 0.100 |
Why?
| California | 2 | 2018 | 367 | 0.100 |
Why?
| C-Reactive Protein | 1 | 2014 | 364 | 0.100 |
Why?
| Cross-Sectional Studies | 2 | 2017 | 4435 | 0.100 |
Why?
| Interleukins | 1 | 2014 | 238 | 0.100 |
Why?
| Bone Morphogenetic Proteins | 1 | 2012 | 133 | 0.100 |
Why?
| Obesity | 3 | 2016 | 2517 | 0.100 |
Why?
| Aspirin | 1 | 2014 | 326 | 0.100 |
Why?
| Neovascularization, Pathologic | 1 | 2013 | 283 | 0.100 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 301 | 0.100 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 350 | 0.100 |
Why?
| Genome | 1 | 2014 | 271 | 0.100 |
Why?
| Universities | 1 | 2014 | 340 | 0.100 |
Why?
| Registries | 3 | 2018 | 1770 | 0.100 |
Why?
| Perception | 1 | 2014 | 315 | 0.100 |
Why?
| Telomerase | 1 | 2013 | 206 | 0.090 |
Why?
| Risk | 4 | 2015 | 819 | 0.090 |
Why?
| Telomere | 1 | 2013 | 204 | 0.090 |
Why?
| Dietary Fats | 2 | 2015 | 289 | 0.090 |
Why?
| Anxiety | 1 | 2017 | 853 | 0.090 |
Why?
| Breast | 3 | 2017 | 138 | 0.090 |
Why?
| Research | 1 | 2014 | 396 | 0.090 |
Why?
| Cross Infection | 1 | 2012 | 202 | 0.090 |
Why?
| Risk Assessment | 4 | 2022 | 2987 | 0.090 |
Why?
| RNA | 1 | 2016 | 819 | 0.090 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 192 | 0.090 |
Why?
| Weight Gain | 1 | 2013 | 453 | 0.080 |
Why?
| Mammary Glands, Human | 1 | 2010 | 60 | 0.080 |
Why?
| Population Surveillance | 3 | 2018 | 395 | 0.080 |
Why?
| Mammary Glands, Animal | 1 | 2010 | 116 | 0.080 |
Why?
| Male | 9 | 2017 | 55949 | 0.080 |
Why?
| Gene-Environment Interaction | 3 | 2015 | 184 | 0.080 |
Why?
| Natural Language Processing | 1 | 2010 | 71 | 0.080 |
Why?
| Depression | 1 | 2017 | 1145 | 0.080 |
Why?
| Macrophage Activation | 1 | 2010 | 165 | 0.080 |
Why?
| Proteomics | 2 | 2006 | 859 | 0.080 |
Why?
| Transcription Factors | 2 | 2013 | 1528 | 0.080 |
Why?
| Follow-Up Studies | 4 | 2021 | 4440 | 0.080 |
Why?
| Staphylococcal Infections | 1 | 2012 | 337 | 0.080 |
Why?
| Liver | 1 | 2016 | 1690 | 0.080 |
Why?
| Ovarian Neoplasms | 1 | 2013 | 407 | 0.080 |
Why?
| Research Design | 1 | 2014 | 946 | 0.070 |
Why?
| Collagen | 1 | 2010 | 415 | 0.070 |
Why?
| Colorectal Neoplasms | 2 | 2006 | 617 | 0.070 |
Why?
| Family Health | 1 | 2008 | 195 | 0.070 |
Why?
| Biomarkers | 3 | 2010 | 3466 | 0.070 |
Why?
| Neoplasm Staging | 3 | 2016 | 1178 | 0.070 |
Why?
| Chi-Square Distribution | 1 | 2008 | 499 | 0.070 |
Why?
| Colorado | 2 | 2014 | 4113 | 0.070 |
Why?
| Eye Proteins | 1 | 2007 | 73 | 0.070 |
Why?
| Cornea | 1 | 2007 | 107 | 0.070 |
Why?
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 5 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2008 | 1718 | 0.070 |
Why?
| DNA-Binding Proteins | 1 | 2013 | 1316 | 0.070 |
Why?
| Lens, Crystalline | 1 | 2007 | 96 | 0.070 |
Why?
| Genetic Linkage | 1 | 2006 | 297 | 0.070 |
Why?
| DNA, Complementary | 1 | 2006 | 258 | 0.060 |
Why?
| Patient Compliance | 1 | 2009 | 524 | 0.060 |
Why?
| International Agencies | 1 | 2005 | 29 | 0.060 |
Why?
| World Health Organization | 1 | 2005 | 106 | 0.060 |
Why?
| Cataract | 1 | 2007 | 185 | 0.060 |
Why?
| Antioxidants | 1 | 2008 | 533 | 0.060 |
Why?
| Prevalence | 1 | 2010 | 2264 | 0.060 |
Why?
| Cause of Death | 2 | 2016 | 368 | 0.060 |
Why?
| Sex Distribution | 1 | 2005 | 337 | 0.060 |
Why?
| Antidepressive Agents | 1 | 2005 | 195 | 0.060 |
Why?
| Gene Frequency | 1 | 2005 | 485 | 0.060 |
Why?
| Retinal Dehydrogenase | 2 | 2017 | 38 | 0.060 |
Why?
| Databases, Bibliographic | 1 | 2003 | 29 | 0.060 |
Why?
| Genome-Wide Association Study | 3 | 2015 | 1217 | 0.060 |
Why?
| Signal Transduction | 5 | 2016 | 4541 | 0.060 |
Why?
| Linear Models | 1 | 2005 | 776 | 0.050 |
Why?
| Macrophages | 1 | 2010 | 1284 | 0.050 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2016 | 2098 | 0.050 |
Why?
| Amino Acid Sequence | 1 | 2006 | 2000 | 0.050 |
Why?
| Survival Analysis | 2 | 2017 | 1219 | 0.050 |
Why?
| Homeostasis | 2 | 2016 | 577 | 0.050 |
Why?
| Pregnancy | 3 | 2022 | 5548 | 0.050 |
Why?
| Molecular Sequence Data | 1 | 2006 | 2790 | 0.050 |
Why?
| Receptor, ErbB-2 | 1 | 2004 | 302 | 0.050 |
Why?
| Mice, Transgenic | 1 | 2006 | 1970 | 0.050 |
Why?
| Hemostasis | 1 | 2001 | 67 | 0.050 |
Why?
| Survivors | 2 | 2016 | 404 | 0.050 |
Why?
| Societies, Medical | 1 | 2005 | 684 | 0.050 |
Why?
| Age of Onset | 2 | 2016 | 450 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 4773 | 0.050 |
Why?
| Adolescent | 4 | 2021 | 17889 | 0.050 |
Why?
| Neoplasm Invasiveness | 2 | 2016 | 445 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2022 | 1805 | 0.040 |
Why?
| Survival Rate | 2 | 2014 | 1650 | 0.040 |
Why?
| Ethanol | 1 | 2004 | 548 | 0.040 |
Why?
| Computational Biology | 1 | 2003 | 536 | 0.040 |
Why?
| Biomedical Research | 1 | 2005 | 588 | 0.040 |
Why?
| Proportional Hazards Models | 1 | 2022 | 1087 | 0.040 |
Why?
| Animals | 5 | 2016 | 32102 | 0.040 |
Why?
| Genomics | 1 | 2003 | 645 | 0.040 |
Why?
| Cohort Studies | 2 | 2022 | 4944 | 0.040 |
Why?
| Lipids | 1 | 2001 | 588 | 0.040 |
Why?
| Mice | 3 | 2010 | 15052 | 0.040 |
Why?
| Myocardial Infarction | 1 | 2004 | 931 | 0.040 |
Why?
| Rats, Inbred SHR | 1 | 2016 | 41 | 0.030 |
Why?
| Lod Score | 1 | 2016 | 65 | 0.030 |
Why?
| Gene Ontology | 1 | 2016 | 47 | 0.030 |
Why?
| Poultry | 1 | 2016 | 9 | 0.030 |
Why?
| Red Meat | 1 | 2016 | 13 | 0.030 |
Why?
| Neuropeptide Y | 1 | 2016 | 13 | 0.030 |
Why?
| Cholecystokinin | 1 | 2016 | 15 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 278 | 0.030 |
Why?
| Receptors, Ghrelin | 1 | 2016 | 7 | 0.030 |
Why?
| Receptors, Leptin | 1 | 2016 | 24 | 0.030 |
Why?
| SEER Program | 1 | 2016 | 195 | 0.030 |
Why?
| Prospective Studies | 2 | 2013 | 6264 | 0.030 |
Why?
| Interviews as Topic | 2 | 2008 | 596 | 0.030 |
Why?
| Linkage Disequilibrium | 1 | 2016 | 247 | 0.030 |
Why?
| Fishes | 1 | 2016 | 81 | 0.030 |
Why?
| Survival | 1 | 2015 | 37 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 451 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2015 | 1 | 0.030 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 2015 | 12 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 14 | 1 | 2015 | 6 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 8 | 1 | 2015 | 15 | 0.030 |
Why?
| Meat | 1 | 2016 | 86 | 0.030 |
Why?
| Dual-Specificity Phosphatases | 1 | 2015 | 10 | 0.030 |
Why?
| Immune System | 1 | 2016 | 173 | 0.030 |
Why?
| Dietary Fiber | 1 | 2015 | 40 | 0.030 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2014 | 11 | 0.030 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2014 | 17 | 0.030 |
Why?
| Janus Kinase 1 | 1 | 2014 | 23 | 0.030 |
Why?
| Population Groups | 1 | 2015 | 58 | 0.030 |
Why?
| Janus Kinase 2 | 1 | 2014 | 31 | 0.030 |
Why?
| MAP Kinase Kinase Kinases | 1 | 2015 | 68 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2014 | 64 | 0.030 |
Why?
| Quantitative Trait Loci | 1 | 2016 | 313 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 165 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2016 | 390 | 0.030 |
Why?
| Folic Acid | 1 | 2015 | 159 | 0.030 |
Why?
| Genes, sis | 1 | 2013 | 1 | 0.030 |
Why?
| Fibroblast Growth Factor 1 | 1 | 2013 | 11 | 0.030 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2013 | 21 | 0.030 |
Why?
| Genes, erbB-2 | 1 | 2013 | 26 | 0.030 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2013 | 21 | 0.030 |
Why?
| Matrix Metalloproteinase 3 | 1 | 2013 | 23 | 0.030 |
Why?
| DNA, Neoplasm | 1 | 2013 | 157 | 0.030 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 88 | 0.030 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 68 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 2013 | 73 | 0.030 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2013 | 56 | 0.030 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2013 | 83 | 0.030 |
Why?
| Peroxidase | 1 | 2013 | 157 | 0.030 |
Why?
| Genomic Instability | 1 | 2013 | 38 | 0.030 |
Why?
| Platinum | 1 | 2013 | 40 | 0.030 |
Why?
| Drug Interactions | 1 | 2014 | 347 | 0.030 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2013 | 160 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 2013 | 161 | 0.030 |
Why?
| New Mexico | 1 | 2013 | 59 | 0.030 |
Why?
| Arizona | 1 | 2013 | 67 | 0.030 |
Why?
| Molecular Typing | 1 | 2012 | 17 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2014 | 316 | 0.030 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2013 | 117 | 0.030 |
Why?
| Bacterial Typing Techniques | 1 | 2012 | 41 | 0.030 |
Why?
| Homozygote | 1 | 2013 | 186 | 0.030 |
Why?
| Ohio | 1 | 2012 | 136 | 0.030 |
Why?
| Heterozygote | 1 | 2013 | 252 | 0.030 |
Why?
| Energy Intake | 1 | 2015 | 414 | 0.030 |
Why?
| Catheterization | 1 | 2012 | 159 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 249 | 0.020 |
Why?
| Smoking Cessation | 1 | 2015 | 377 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2013 | 621 | 0.020 |
Why?
| Stress, Physiological | 1 | 2014 | 399 | 0.020 |
Why?
| Microbial Sensitivity Tests | 1 | 2012 | 299 | 0.020 |
Why?
| Haplotypes | 1 | 2012 | 457 | 0.020 |
Why?
| Transcriptome | 1 | 2016 | 736 | 0.020 |
Why?
| Alleles | 1 | 2013 | 794 | 0.020 |
Why?
| Surveys and Questionnaires | 2 | 2015 | 4665 | 0.020 |
Why?
| Cell Movement | 2 | 2006 | 867 | 0.020 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2013 | 503 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2016 | 2416 | 0.020 |
Why?
| Weaning | 1 | 2010 | 48 | 0.020 |
Why?
| Renal Dialysis | 1 | 2012 | 369 | 0.020 |
Why?
| Drug Resistance, Neoplasm | 1 | 2013 | 638 | 0.020 |
Why?
| Respiration, Artificial | 1 | 2012 | 526 | 0.020 |
Why?
| Tocopherols | 1 | 2008 | 22 | 0.020 |
Why?
| Body Weight | 1 | 2013 | 867 | 0.020 |
Why?
| Species Specificity | 1 | 2010 | 552 | 0.020 |
Why?
| Carotenoids | 1 | 2008 | 35 | 0.020 |
Why?
| Vitamin A | 1 | 2008 | 52 | 0.020 |
Why?
| Diet Records | 1 | 2008 | 76 | 0.020 |
Why?
| Confidence Intervals | 1 | 2008 | 309 | 0.020 |
Why?
| Ascorbic Acid | 1 | 2008 | 112 | 0.020 |
Why?
| Time Factors | 1 | 2017 | 6165 | 0.020 |
Why?
| Factor Analysis, Statistical | 1 | 2008 | 261 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2007 | 136 | 0.020 |
Why?
| Disease Progression | 1 | 2013 | 2418 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2010 | 439 | 0.020 |
Why?
| Attitude to Health | 1 | 2009 | 409 | 0.020 |
Why?
| Glutathione | 1 | 2007 | 303 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2010 | 2262 | 0.020 |
Why?
| Ultraviolet Rays | 1 | 2007 | 372 | 0.010 |
Why?
| Mood Disorders | 1 | 2005 | 117 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2007 | 924 | 0.010 |
Why?
| Receptors, Estradiol | 1 | 2003 | 3 | 0.010 |
Why?
| Software Validation | 1 | 2003 | 7 | 0.010 |
Why?
| Forecasting | 1 | 2005 | 333 | 0.010 |
Why?
| Motor Activity | 1 | 2008 | 633 | 0.010 |
Why?
| MEDLINE | 1 | 2003 | 22 | 0.010 |
Why?
| Arteriosclerosis | 1 | 2003 | 83 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 1484 | 0.010 |
Why?
| Feasibility Studies | 1 | 2006 | 741 | 0.010 |
Why?
| Disease | 1 | 2003 | 87 | 0.010 |
Why?
| Databases, Genetic | 1 | 2003 | 208 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2004 | 850 | 0.010 |
Why?
| Double-Blind Method | 1 | 2006 | 1660 | 0.010 |
Why?
| Cluster Analysis | 1 | 2003 | 465 | 0.010 |
Why?
| Rats | 1 | 2010 | 5034 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2003 | 324 | 0.010 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 1198 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 746 | 0.010 |
Why?
| Bipolar Disorder | 1 | 2003 | 208 | 0.010 |
Why?
| Mice, Knockout | 1 | 2007 | 2604 | 0.010 |
Why?
| Comorbidity | 1 | 2005 | 1473 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2006 | 1536 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2006 | 2751 | 0.010 |
Why?
| Gene Expression | 1 | 2003 | 1435 | 0.010 |
Why?
| Epithelial Cells | 1 | 2004 | 961 | 0.010 |
Why?
| Exercise | 1 | 2008 | 1609 | 0.010 |
Why?
| Aging | 1 | 2007 | 1631 | 0.010 |
Why?
| Hypertension | 1 | 2003 | 1064 | 0.010 |
Why?
| Arthritis, Rheumatoid | 1 | 2003 | 1002 | 0.010 |
Why?
|
|
Hines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|